| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/21/2004 | WO2003104404A8 Cancer-linked gene as target for chemotherapy |
| 05/21/2004 | WO2003102190A3 Bacterial polypeptides involved in viability |
| 05/21/2004 | WO2003080105A3 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof |
| 05/21/2004 | WO2003077835A9 Sodium dodecyl sulfate compositions for inactivating prions |
| 05/21/2004 | WO2003076584A8 Novel proteins and nucleic acids encoding same |
| 05/21/2004 | WO2003072725A3 Recombinant negative strand virus rna expression systems and vaccines |
| 05/21/2004 | WO2003055440A8 Compositions and methods for the treatement of immune related diseases |
| 05/21/2004 | WO2003053135A9 Plant xrcc3 genes and methods of use |
| 05/21/2004 | WO2003042362A8 PGC-1β, A NOVEL PGC-1 HOMOLOGUE AND USES THEREFOR |
| 05/21/2004 | WO2003040296A8 Men protein, gst2, rab-rp1, csp, f-box protein lilina/fbl7, abc50, coronin, sec61 alpha, or vhappa1-1, or homologous proteins involved in the regulation of energy homeostasis |
| 05/21/2004 | WO2003004684A3 NUCLEIC ACIDS ENCODING A RECOMBINANT 250 kDa ANTIGEN FROM SPOROZOITES/MEROZOITES OF EIMERIA MAXIMA AND THEIR USES |
| 05/21/2004 | WO2002102306A8 Methods and compositions for inhibiting, preventing, or reducing tumor cell growth in patients resistant to the antineoplastic effects of antiestrogen therapy |
| 05/21/2004 | WO2002074791A8 Method for purification of molecules using unbranched terminal alkyldiols |
| 05/21/2004 | WO2002070538A8 Narc8 programmed cell-death-associated molecules and uses thereof |
| 05/21/2004 | WO2002061105A8 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc) |
| 05/21/2004 | WO2002060163A3 Methods for increasing bone formation and enhancing bone accretion |
| 05/21/2004 | WO2002040674A9 '67118', '67067' and '62092', human proteins and methods of use thereof |
| 05/21/2004 | WO2002014467A8 Cng2b: a putative human cyclic nucleotide-gated ion channel |
| 05/21/2004 | WO2001066690A3 Novel compounds |
| 05/21/2004 | WO2000066068A3 Method for inducing growth and enhancing survival of nervous tissue |
| 05/21/2004 | WO2000058340A3 50 human secreted proteins |
| 05/21/2004 | WO2000032745A3 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof |
| 05/21/2004 | CA2545304A1 Method of immobilising a protein to a zeolite |
| 05/21/2004 | CA2543376A1 Interferon antagonists useful for the treatment of interferon related diseases |
| 05/21/2004 | CA2505476A1 Neuroprotective iron chelators and pharmaceutical compositions comprising them |
| 05/21/2004 | CA2505400A1 Improving growth characteristics of filamentous microorganisms |
| 05/21/2004 | CA2505209A1 Hiv vaccine |
| 05/21/2004 | CA2505208A1 Hiv vaccine |
| 05/21/2004 | CA2504830A1 Organic anion transport polypeptide related protein-4 (oatprp4) gene in tourette syndrome and related disorders |
| 05/21/2004 | CA2504762A1 P153 and p156 antigens for the immunodiagnosis of canine and human ehrlichioses and uses thereof |
| 05/21/2004 | CA2504711A1 Hcv vaccine compositions comprising e1 and ns3 peptides |
| 05/21/2004 | CA2504270A1 Peptide fragments of the harp factor inhibiting angiogenesis |
| 05/21/2004 | CA2504035A1 Amyloid plaque formation by glycosaminoglycans |
| 05/21/2004 | CA2503546A1 Pharmaceutical composition for preparing a medicine for treating and/or preventing a pathology related to an obsessive behaviour or obesity |
| 05/21/2004 | CA2503390A1 Compositions and methods for the treatment of immune related diseases |
| 05/21/2004 | CA2501514A1 Human type ii diabetes gene-slit-3 located on chromosome 5q35 |
| 05/20/2004 | US20040098769 Comprises nucleotide sequences coding single-stranded DNA-binding protein for modulating DNA replication, repair and recombination; tissue engineering |
| 05/20/2004 | US20040098767 Comprises nucleotide sequences coding protein intermediate-1 for use in modifying flowering in plants |
| 05/20/2004 | US20040098763 Modulation of plant cyclin-dependent kinase inhibitor activity |
| 05/20/2004 | US20040098762 Comprises nucleotide sequences coding desaturase for insertion of a double bond into a fatty acyl moiety at the twelfth or fifteenth carbon position in fatty acyl chain; improving vegetable oils |
| 05/20/2004 | US20040098761 Compositions and methods for controlling parasitic nematodes |
| 05/20/2004 | US20040098760 Transcriptional regulatory nucleic acids, polypeptides and methods of use thereof |
| 05/20/2004 | US20040098758 Method for modifying a plant phenotype |
| 05/20/2004 | US20040098757 Rodent model homozygous for membrane protein defect associated with angina and arrhythmias for identifying modulators of cardiovascular and cardiac disorders |
| 05/20/2004 | US20040098755 Comprises nucleotide sequences coding embryonic glycoprotein for use in the treatment and prevention of autoimmune, cell proliferative and immunological disorders; immunosuppressants; antiproliferative agents |
| 05/20/2004 | US20040097721 Pesticidal toxins and genes from Bacillus laterosporus strains |
| 05/20/2004 | US20040097720 Use of glycodendrimer reagents for inhibiting adhesion by microorganisms |
| 05/20/2004 | US20040097718 Complete nucleotide sequence of staphlococcus aureus ribosomal protein gene, s20 and methods for the identification of antibacterial substances |
| 05/20/2004 | US20040097717 Comprises nucleotide sequences coding polypeptide associated with abscisic acid (ABA) biosynthesis and for controlling preharvest sprouting in plants; agriculture and genetic engineering |
| 05/20/2004 | US20040097715 Recovering polypeptides which have leached from cells made porous via electric pulse |
| 05/20/2004 | US20040097714 Using microfiltration and/or diafiltration to isolate transforming growth factor from dairy products for use in treatment and prevention of cell proliferative, autoimmune, bone and inflammatory disorders; antitumor agents |
| 05/20/2004 | US20040097710 Method for the crystallization of human serum albumin |
| 05/20/2004 | US20040097708 Comprises nucleotide sequences coding membrane protein associated with odor detection for use in biological pest control |
| 05/20/2004 | US20040097707 Receptors and membrane-associated proteins |
| 05/20/2004 | US20040097706 Streptococcus pyogenes antigens and corresponding dna fragments |
| 05/20/2004 | US20040097705 Small acid-soluble spore protein and uses thereof |
| 05/20/2004 | US20040097704 Allelic opiate membrane protein for determining susceptibility of individuals to addictive diseases; monitoring response to analgesics and learning enhancement agents |
| 05/20/2004 | US20040097703 Cancer antigen peptide for treatment cell proliferative and cancer disorders |
| 05/20/2004 | US20040097540 Adenosine a2a receptor antangonists combined with neurotrophic activity compounds in the treatment of parkinson's disease |
| 05/20/2004 | US20040097458 Providing microprojectiles carrying polynucleic acid sequences; accelerating the microprojectiles at the preselected-cells, with the microprojectiles contacting cells to penetrate vertebrate cells and deposit polynucleic acid |
| 05/20/2004 | US20040097457 Protein disulfide isomerase and abc transporter homologous proteins involved in the regulation of energy homeostasis |
| 05/20/2004 | US20040097454 Method for modulation of cell phenotype |
| 05/20/2004 | US20040097453 Introducing to the subject, or to a target group of cells from the subject, an expressible polynucleotide encoding a eukaryotic heat shock protein for stimulating a therapeutic immune response |
| 05/20/2004 | US20040097418 Somatostatin antagonists |
| 05/20/2004 | US20040097415 Controlling blood glucose concentration; amylin antagonist |
| 05/20/2004 | US20040097414 Genetic engineered Dna; gene therapy |
| 05/20/2004 | US20040097412 Non-mammalian GnRH analogs and uses thereof in tumor cell growth regulation and cancer therapy |
| 05/20/2004 | US20040097409 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 05/20/2004 | US20040097402 Therapy for infections; bactericides; synergistic mixtures |
| 05/20/2004 | US20040096973 Diagnosing and preventing microorganismal infections using iron-restricted conditions; genetic vaccines |
| 05/20/2004 | US20040096972 Chimeric plasmid comprising a replicative retroviral genome, and uses |
| 05/20/2004 | US20040096965 Activator of fibronectin binding protein and method of its preparation |
| 05/20/2004 | US20040096954 Protein AMSH and cDNA thereof |
| 05/20/2004 | US20040096953 Thrombin derivatives and process for producing the same, anhydrothrombin derivatives and process for producing the same, platelet agglutination-inducing composition, method of inducing platelet agglutination, clinical test reagents, clinical test method, thrombosis inhibitors, adsorbent and process for producing the same, |
| 05/20/2004 | US20040096945 Nucleic acids and protein variants of hG-CSF with granulopoietic activity |
| 05/20/2004 | US20040096944 Methods for producing biological substances in pigment-deficient mutants of bacillus cells |
| 05/20/2004 | US20040096942 Chimeric retinoid X receptors and their use in a novel ecdysone receptor-based inducible gene expression system |
| 05/20/2004 | US20040096941 Comprise phytosulfokine (PSK) receptor protein for regulating plant growth rates |
| 05/20/2004 | US20040096940 Novel polypeptides having opioid receptor activity, nucleic acids coding therefor and uses thereof |
| 05/20/2004 | US20040096939 Modifier of organelle metabolism |
| 05/20/2004 | US20040096938 Method for generating split, non-transferable genes that are able to express an active protein product |
| 05/20/2004 | US20040096936 Comprises nucleotide sequences coding fibroblast growth factor (FGF) for treating cardiac disorders; tissue engineering; tissue-targeted gene therapy |
| 05/20/2004 | US20040096935 Antibodies against interleukin-17 receptor like protein |
| 05/20/2004 | US20040096934 Pepsin-sensitive modified Bacillus thuringiensis insecticidal toxin |
| 05/20/2004 | US20040096922 NPHP nucleic acids and proteins |
| 05/20/2004 | US20040096913 Cloning and expression of a new MCP receptor in glial cells |
| 05/20/2004 | US20040096912 Identifying antipain agents for use in post-operative pain management |
| 05/20/2004 | US20040096894 Three dimensional structure of cell surface glycoprotein for screening and designing drugs for treatment of inflammation |
| 05/20/2004 | US20040096888 Comprises nucleotide sequences coding cyclin dependent kinase (PELOTA) for diagnosis, treatment, prognosis and prevention of cell proliferative, cardoivascular, inflammatory, arthritic disorders |
| 05/20/2004 | US20040096886 Using sodium channel (SCNA) expresion to detect nervous system disorders; antitpileptic agents |
| 05/20/2004 | US20040096885 Using sodium channel (SCNA) expresion to detect nervous system disorders; antitpileptic agents |
| 05/20/2004 | US20040096877 For diagnosis/treatment/prevention of inflammation/asthma/ allergies |
| 05/20/2004 | US20040096875 Comprises polynucleotide derived from rise; genetic engineering |
| 05/20/2004 | US20040096861 For increase the drought tolerance of plants; gene expression inhibition |
| 05/20/2004 | US20040096860 For engines/machines; comprises complexing agents; chemical linkers |
| 05/20/2004 | US20040096852 Mixed fibrils |
| 05/20/2004 | US20040096851 ABCA1 PEST domain-related compositions and methods |
| 05/20/2004 | US20040096847 Regulation of human secretin receptor-like gpcr |
| 05/20/2004 | US20040096842 Molecules involved in the regulation of insulin resistance syndrome (irs) |
| 05/20/2004 | US20040096828 Cytoskeleton-associated proteins |